Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.880
-0.100 (-3.36%)
At close: Aug 10, 2026, 4:00 PM EDT
2.910
+0.030 (1.04%)
After-hours: Aug 10, 2026, 7:57 PM EDT
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.3 million as of August 10, 2026. Its market cap has decreased by -32.56% in one year.
Market Cap
2.30M
Enterprise Value
-3.81M
1-Year Change
-32.56%
Ranking
Category
Stock Price
$2.88
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.30M, a decrease of -98.89%. That is a compound annual growth rate of -67.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.30M | -10.58% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Propanc Biopharma | 2.73M |
| GRI Bio | 2.60M |
| Artelo Biosciences | 2.51M |
| Oragenics | 2.48M |
| Clearmind Medicine | 2.42M |
| Azitra | 2.19M |
| Moleculin Biotech | 2.19M |
| CDT Equity | 2.16M |